Optimal unplanned design modification in adaptive two-stage trials

被引:0
|
作者
Pilz, Maximilian [1 ]
Herrmann, Carolin [2 ,3 ,4 ]
Rauch, Geraldine [2 ,3 ,4 ]
Kieser, Meinhard [1 ]
机构
[1] Heidelberg Univ, Univ Med Ctr, Inst Med Biometry, Neuenheimer Feld 130-3, D-69120 Heidelberg, Germany
[2] Charite Univ Med Berlin, Inst Biometry & Clin Epidemiol, Berlin, Germany
[3] Free Univ Berlin, Berlin, Germany
[4] Humboldt Univ, Berlin, Germany
关键词
adaptive design; clinical trial; conditional error principle; optimal design; sample size calculation; SAMPLE-SIZE MODIFICATION; CLINICAL-TRIALS;
D O I
10.1002/pst.2228
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adaptive planning of clinical trials allows modifying the entire trial design at any time point mid-course. In this paper, we consider the case when a trial-external update of the planning assumptions during the ongoing trial makes an unforeseen design adaptation necessary. We take up the idea to construct adaptive designs with defined features by solving an optimization problem and apply it to the situation of unplanned design reassessment. By using the conditional error principle, we present an approach on how to optimally modify the trial design at an unplanned interim analysis while at the same time strictly protecting the type I error rate. This linking of optimal design planning and the conditional error principle allows sound reactions to unforeseen events that make a design reassessment necessary.
引用
收藏
页码:1121 / 1137
页数:17
相关论文
共 50 条
  • [41] A Two-Stage Design for Comparative Clinical Trials: the Heteroscedastic Solution
    Elena M. Buzaianu
    Pinyuen Chen
    Sankhya B, 2018, 80 (1) : 151 - 177
  • [42] A Generalized Framework of Optimal Two-Stage Designs for Exploratory Basket Trials
    Wu, Xiaoqiang
    Wu, Cai
    Liu, Fang
    Zhou, Heng
    Chen, Cong
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2021, 13 (03): : 286 - 294
  • [43] Conditionally unbiased estimation in two-stage adaptive trials with unknown variances
    Robertson, David
    Glimm, Ekkehard
    TRIALS, 2017, 18
  • [44] Optimal two-stage designs for clinical trials based on safety and efficacy
    Thall, PF
    Cheng, SC
    STATISTICS IN MEDICINE, 2001, 20 (07) : 1023 - 1032
  • [45] A robust two-stage design identifying the optimal biological dose for phase I/II clinical trials
    Zang, Yong
    Lee, J. Jack
    STATISTICS IN MEDICINE, 2017, 36 (01) : 27 - 42
  • [46] Analysis of Time-to-Event Data Under a Two-Stage Survival Adaptive Design in Clinical Trials
    Lu, Qingshu
    Tse, Siu Keung
    Chow, Shein-Chung
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (04) : 705 - 719
  • [47] Automated optimal design of a two-stage helical gear reducer
    Tudose, Lucian
    Buiga, Ovidiu
    Stefanache, Cornel
    Sobester, Andras
    STRUCTURAL AND MULTIDISCIPLINARY OPTIMIZATION, 2010, 42 (03) : 429 - 435
  • [48] Optimal design of symmetrical two-stage flat reflected concentrator
    Meng, Xianlong
    Xia, Xinlin
    Sun, Chuang
    Dai, Guilong
    SOLAR ENERGY, 2013, 93 : 334 - 344
  • [49] Parameter analysis and optimal design for two-stage thermoelectric cooler
    Wang, Tian-Hu
    Wang, Qiu-Hong
    Leng, Chuan
    Wang, Xiao-Dong
    APPLIED ENERGY, 2015, 154 : 1 - 12
  • [50] Optimal two-stage enrichment design correcting for biomarker misclassification
    Zang, Yong
    Guo, Beibei
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2018, 27 (01) : 35 - 47